Alcon Results Pose Questions About 2027 Outlook

Dow Jones
11/11

1056 GMT - Alcon's third-quarter results were worse than expected and raise questions about the eyecare specialist's outlook for next year, Jefferies analysts say in a note. Investors had lower expectations for the third-quarter results, but the update was still worse than anticipated, the analysts say. Revenue missed consensus estimates and full-year guidance was mostly lowered at the midpoint of the new narrowed ranges, even if third-quarter earnings beat forecasts, they add. Competitive pressure that has weighed on sales of Alcon's implantable products could persist into the fourth quarter, Jefferies says. Zurich-listed shares fall 5.6%.

 

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10